Notable News Spotlight: Valeritas Holdings (VLRX)

Valeritas Holdings (VLRX) spotted trading -92.18% off 52-week high price. On the other end, the stock has been noted 40.00% away from the low price over the last 52-weeks. The stock changed 4.26% to recent value of $2.94. The stock transacted 862697 shares during most recent day however it has an average volume of 331.48K shares. The company has 5.34M of outstanding shares and 4.28M shares were floated in the market.  

Valeritas Holdings (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, reported positive data from a retrospective study using the HealthCore Integrated Research Database (HIRD) comparing patients using V-Go to patients using multiple daily injection (MDI) therapy. The study demonstrates V-Go users experienced lower insulin dose requirements and lower diabetes-related medication cost while lowering average blood sugar levels, as measured by A1c.

John Timberlake, President and Chief Executive Officer of Valeritas said “We view this study as a confirmation of both the clinical and economic benefits V-Go provides patients,”. “V-Go has always offered the improvements in insulin adherence associated with removing multiple daily injections for patients with type 2 diabetes requiring daily insulin, and this study provides additional long-term data demonstrating the economic advantages of our cost-effective alternative.”

Results from the study demonstrate that despite similar baseline insulin Rx fills and diabetes medication costs, V-Go users required fewer insulin Rx fills (mean change: -0.8 vs. +1.8 fills, p<0.001; -17% vs. +38%), had a smaller increase in diabetes medication costs (mean change in 2016 USD: $341 vs. $1,628, p=0.012; +10% vs. +47%), and a decrease in insulin total daily dose (TDD) (mean change in insulin units/day: -29.2 vs. +5.8, p<0.001; -21% vs. +4%), compared to MDI users, during the last six months of follow-up.

 Its earnings per share (EPS) expected to touch remained 80.90% for this year . VLRX has a gross margin of 47.10% . 

 According to the most recent quarter its current ratio was 3.3 that represents company’s ability to meet its current financial obligations. The price moved ahead of 1.11% from the mean of 20 days, -28.48% from mean of 50 days SMA and performed -70.65% from mean of 200 days price. Company’s performance for the week was 13.08%, -15.76% for month and YTD performance remained -54.84%.

Leave a Reply

Your email address will not be published. Required fields are marked *